460 related articles for article (PubMed ID: 33397366)
1. Vaccination strategies for measles control and elimination: time to strengthen local initiatives.
Cutts FT; Ferrari MJ; Krause LK; Tatem AJ; Mosser JF
BMC Med; 2021 Jan; 19(1):2. PubMed ID: 33397366
[TBL] [Abstract][Full Text] [Related]
2. Strengthening routine immunization through measles-rubella elimination.
Biellik RJ; Orenstein WA
Vaccine; 2018 Sep; 36(37):5645-5650. PubMed ID: 30041881
[TBL] [Abstract][Full Text] [Related]
3. Progress towards measles elimination in Eritrea: 2003 - 2018.
Yehdego T; Yhdego TK; Masresha B; Gebreslassie A; Katsande R; Fussum D; Lebo E; Namboze J
Pan Afr Med J; 2020; 35(Suppl 1):7. PubMed ID: 32373258
[TBL] [Abstract][Full Text] [Related]
4. Progress Toward Measles Elimination - Pakistan, 2000-2018.
Mere MO; Goodson JL; Chandio AK; Rana MS; Hasan Q; Teleb N; Alexander JP
MMWR Morb Mortal Wkly Rep; 2019 Jun; 68(22):505-510. PubMed ID: 31170125
[TBL] [Abstract][Full Text] [Related]
5. Impact of disruptions to routine vaccination programs, quantifying burden of measles, and mapping targeted supplementary immunization activities.
Kostandova N; Loisate S; Winter A; Moss WJ; Giles JR; Metcalf CJE; Mutembo S; Wesolowski A
Epidemics; 2022 Dec; 41():100647. PubMed ID: 36343498
[TBL] [Abstract][Full Text] [Related]
6. Demographics, epidemiology and the impact of vaccination campaigns in a measles-free world - Can elimination be maintained?
Prada JM; Metcalf CJE; Takahashi S; Lessler J; Tatem AJ; Ferrari M
Vaccine; 2017 Mar; 35(11):1488-1493. PubMed ID: 28216186
[TBL] [Abstract][Full Text] [Related]
7. Progress Toward Measles Elimination - African Region, 2013-2016.
Masresha BG; Dixon MG; Kriss JL; Katsande R; Shibeshi ME; Luce R; Fall A; Dosseh ARGA; Byabamazima CR; Dabbagh AJ; Goodson JL; Mihigo R
MMWR Morb Mortal Wkly Rep; 2017 May; 66(17):436-443. PubMed ID: 28472026
[TBL] [Abstract][Full Text] [Related]
8. Measles control in Sub-Saharan Africa: South Africa as a case study.
Verguet S; Jassat W; Hedberg C; Tollman S; Jamison DT; Hofman KJ
Vaccine; 2012 Feb; 30(9):1594-600. PubMed ID: 22230581
[TBL] [Abstract][Full Text] [Related]
9. Progress Toward Measles Elimination - Western Pacific Region, 2013-2017.
Hagan JE; Kriss JL; Takashima Y; Mariano KML; Pastore R; Grabovac V; Dabbagh AJ; Goodson JL
MMWR Morb Mortal Wkly Rep; 2018 May; 67(17):491-495. PubMed ID: 29723171
[TBL] [Abstract][Full Text] [Related]
10. Progress Toward Measles Elimination - Eastern Mediterranean Region, 2013-2019.
Goodson JL; Teleb N; Ashmony H; Musa N; Ghoniem A; Hassan Q; Waciqi AS; Mere MO; Farid M; Mukhtar HEA; Iqbal J; Alexander JP
MMWR Morb Mortal Wkly Rep; 2020 Apr; 69(15):439-445. PubMed ID: 32298253
[TBL] [Abstract][Full Text] [Related]
11. Impact of measles supplementary immunization activities on reaching children missed by routine programs.
Portnoy A; Jit M; Helleringer S; Verguet S
Vaccine; 2018 Jan; 36(1):170-178. PubMed ID: 29174680
[TBL] [Abstract][Full Text] [Related]
12. Health effects of routine measles vaccination and supplementary immunisation activities in 14 high-burden countries: a Dynamic Measles Immunization Calculation Engine (DynaMICE) modelling study.
Auzenbergs M; Fu H; Abbas K; Procter SR; Cutts FT; Jit M
Lancet Glob Health; 2023 Aug; 11(8):e1194-e1204. PubMed ID: 37474227
[TBL] [Abstract][Full Text] [Related]
13. Progress Toward Measles Elimination - European Region, 2009-2018.
Zimmerman LA; Muscat M; Singh S; Ben Mamou M; Jankovic D; Datta S; Alexander JP; Goodson JL; O'Connor P
MMWR Morb Mortal Wkly Rep; 2019 May; 68(17):396-401. PubMed ID: 31048675
[TBL] [Abstract][Full Text] [Related]
14. Impact of COVID-19-related disruptions to measles, meningococcal A, and yellow fever vaccination in 10 countries.
Gaythorpe KA; Abbas K; Huber J; Karachaliou A; Thakkar N; Woodruff K; Li X; Echeverria-Londono S; ; Ferrari M; Jackson ML; McCarthy K; Perkins TA; Trotter C; Jit M
Elife; 2021 Jun; 10():. PubMed ID: 34165077
[TBL] [Abstract][Full Text] [Related]
15. Progress Toward Measles Elimination - South-East Asia Region, 2003-2020.
Khanal S; Kassem AM; Bahl S; Jayantha L; Sangal L; Sharfuzzaman M; Bose AS; Antoni S; Datta D; Alexander JP
MMWR Morb Mortal Wkly Rep; 2022 Aug; 71(33):1042-1046. PubMed ID: 35980874
[TBL] [Abstract][Full Text] [Related]
16. Progress toward measles elimination--Eastern Mediterranean Region, 2008-2012.
Teleb N; Lebo E; Ahmed H; Hossam AR; El Sayed el T; Dabbagh A; Strebel P; Rota P; Alexander J;
MMWR Morb Mortal Wkly Rep; 2014 Jun; 63(23):511-5. PubMed ID: 24918486
[TBL] [Abstract][Full Text] [Related]
17. Measles resurgence in southern Africa: challenges to measles elimination.
Shibeshi ME; Masresha BG; Smit SB; Biellik RJ; Nicholson JL; Muitherero C; Shivute N; Walker O; Reggis K; Goodson JL
Vaccine; 2014 Apr; 32(16):1798-807. PubMed ID: 24530936
[TBL] [Abstract][Full Text] [Related]
18. Regional reports for the subnational monitoring of measles elimination in Italy and the identification of local barriers to the attainment of the elimination goal.
Adamo G; Sturabotti G; Baccolini V; de Soccio P; Prencipe GP; Bella A; Magurano F; Iannazzo S; Villari P; Marzuillo C
PLoS One; 2018; 13(10):e0205147. PubMed ID: 30356247
[TBL] [Abstract][Full Text] [Related]
19. Progress Toward Measles Elimination - South-East Asia Region, 2003-2013.
Thapa A; Khanal S; Sharapov U; Swezy V; Sedai T; Dabbagh A; Rota P; Goodson JL; McFarland J;
MMWR Morb Mortal Wkly Rep; 2015 Jun; 64(22):613-7. PubMed ID: 26068565
[TBL] [Abstract][Full Text] [Related]
20. Comparative Distributional Impact of Routine Immunization and Supplementary Immunization Activities in Delivery of Measles Vaccine in Low- and Middle-Income Countries.
Portnoy A; Jit M; Helleringer S; Verguet S
Value Health; 2020 Jul; 23(7):891-897. PubMed ID: 32762991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
